Atrás
32
7
Rango del Día
$13.19
$13.70
Rango de 52 Semanas
$3.92
$14.65
Volumen
119,498
Promedio 50D / 200D
$12.15
/
$8.61
Cierre Anterior
$13.71
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 68.8 | 0.3 |
| P/B | 7.2 | 2.9 |
| ROE % | 11.4 | 3.7 |
| Net Margin % | 14.6 | 3.8 |
| Rev Growth 5Y % | 15.4 | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$30.00
+122.2%
P/E Futuro
70.3
EPS Futuro
$0.20
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
66 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$0.28
$0.27 – $0.29
|
110 M | 1 |
| FY2027 |
$0.28
$0.20 – $0.39
|
81 M | 3 |
| FY2026 |
$0.20
$0.16 – $0.26
|
66 M | 3 |
Puntos Clave
Revenue grew 15.42% annually over 5 years — strong growth
Earnings grew 163.39% over the past year
ROE of 11.35% — decent returns on equity
Debt/Equity of 0.09 — conservative balance sheet
Generating 16.40M in free cash flow
P/E of 68.83 — premium valuation
Crecimiento
Revenue Growth (5Y)
15.42%
Revenue (1Y)28.34%
Earnings (1Y)163.39%
FCF Growth (3Y)N/A
Calidad
Return on Equity
11.35%
ROIC4.08%
Net Margin14.62%
Op. Margin8.28%
Seguridad
Debt / Equity
0.09
Current Ratio3.83
Interest Coverage1.96
Valoración
P/E Ratio
68.83
P/B Ratio7.23
EV/EBITDA107.49
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28.34% | Revenue Growth (3Y) | 28.69% |
| Earnings Growth (1Y) | 163.39% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15.42% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 52.64M | Net Income (TTM) | 7.69M |
| ROE | 11.35% | ROA | 6.81% |
| Gross Margin | 75.42% | Operating Margin | 8.28% |
| Net Margin | 14.62% | Free Cash Flow (TTM) | 16.40M |
| ROIC | 4.08% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.09 | Current Ratio | 3.83 |
| Interest Coverage | 1.96 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 68.83 | P/B Ratio | 7.23 |
| P/S Ratio | 10.06 | PEG Ratio | 0.06 |
| EV/EBITDA | 107.49 | Dividend Yield | 0.00% |
| Market Cap | 529.51M | Enterprise Value | 468.38M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 52.64M | 41.02M | 31.79M | 27.18M | 29.66M |
| Net Income | 7.69M | 2.92M | -4.20M | -13.35M | -6.46M |
| EPS (Diluted) | 0.36 | 0.09 | -0.13 | -0.43 | -0.21 |
| Gross Profit | 39.70M | 30.58M | 23.48M | 20.05M | 23.06M |
| Operating Income | 4.36M | 1.39M | -4.96M | -12.68M | -5.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 112.92M | 94.32M | 62.97M | 64.48M | 75.73M |
| Total Liabilities | 34.67M | 32.00M | 21.39M | 19.08M | 18.41M |
| Shareholders' Equity | 73.22M | 62.31M | 41.58M | 45.40M | 57.33M |
| Total Debt | 6.82M | 5.62M | 471,000.0 | 488,000.0 | 754,000.0 |
| Cash & Equivalents | 67.95M | 69.35M | 10.52M | 47.58M | 16.92M |
| Current Assets | 84.89M | 79.67M | 55.47M | 58.09M | 65.45M |
| Current Liabilities | 22.16M | 15.35M | 9.76M | 8.14M | 9.07M |
Puntuaciones de Estrategias
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#787 of 1052
Custom
Full Throttle
#144 of 146
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026
Entró
Full Throttle
Mar 24, 2026